“Bacteriobot”: Korea Develops First Cancer-treating Nanorobot | BusinessKorea

Saturday, August 01, 2015

A computer-generated image of a bacteriobot in action. A Chonnam National University research team has succeeded in developing bacteriobots that can diagnose and treat cancer.
A computer-generated image of a bacteriobot in action. A Chonnam National University research team has succeeded in developing bacteriobots that can diagnose and treat cancer.
17 December 2013 - 12:00pm

A Korean research team has successfully developed bacteriobots that can diagnose and treat cancer. This bacteria-based robot is expected to be utilized to develop new treatments for cancer and various microrobots or nanorobots for medical purposes in the future.

A bacteriobot research team from Chonnam National University announced on December 16 that it confirmed the propensity of bacteriobots to migrate toward tumors and their tumor targeting ability with animal testing.

According to the team, bacteria and bacteriobots displayed minimal changes in normal cells, but those bacteriobots moved toward tumor cells with increasing speed, and thus cell density grew. In addition, the research team verified bacteriobots’ tumor targeting capability and their existence in tumor tissues by injecting bacteria-based robots into tumor-bearing mice via tail veins and conducting an immunohistochemical study three days after the injection.

Bacteriobots are made up of bacteria and 3µm-sized microstructures filled with anticancer drugs." typeof=

Genetically-modified non-toxic bacteria move inside tissues or blood with flagella, and find tumors by pushing microstructures and targeting certain drugs secreted by cancer cells. Upon the arrival of bacteriobots in the tumor region, anticancer drugs that come from microstructures are spread onto the surface of tumors at a speed of 5µm/s on average.

Park Jong-oh from the School of Mechanical Systems Engineering at Chonnam National University said, “The importance of this research lies in the development of a new medical nanorobot and an active drug delivery carrier that can overcome the limits of conventional methods to diagnose and treat cancer.” Park added, “Our future plan is to develop medical microrobots or nanorobots capable of diagnosing and treating a lot of hard-to-treat illnesses through the convergence of medicine and engineering in our research.”

The research article, titled “New paradigm for tumor theranostic methodology using bacteria-based microrobot,” was published online in the December 2 issue of Scientific Reports, a scientific journal published by the Nature Publishing Group. 


More Like This

A Korean research group has successfully developed a new substance that can slow the spread of cancer cells, pictured above. (Photo courtesy Dr. Cecil Fox/National Cancer Institute)
Development of Anti-Cancer Substance
Tuesday, 12 November 2013
Korea’s Ministry of Science, ICT and Future Planning announced on November 10 that a research team at the Medicinal Bioconvergence Research Center (Biocon) has developed a cancer-suppressing...
New Biomaterial
Wednesday, 06 August 2014
A Korean research team has successfully developed a method to manufacture plastic materials with bacteria. Much attention is being paid to whether or not the method will lead to the replacement of...
An illustration of a cell dying and bursting apart. (Photo via Cognition, Inc.)
Sniper Drug
Wednesday, 03 June 2015
A local research team found out a way to kill cancer cells with only a small amount of an anticancer drug. The study is expected to greatly contribute to lessening patient suffering by making...
Gold nanoparticles that can identify cancer cells are a budding avenue of research.
Advances in Cancer Treatment
Thursday, 10 July 2014
The Ministry of Science, ICT and Future Planning (MSIP) announced on July 9 that a research team led by professor Lee Ji-won from Korea University and Dr. Kim Kwang-myung from the Korea Institute of...
Mechanism of Opus: (A) Drug (purple object) cannot normally enter a tumor cell. (B) Opus (green arrow) breaks open closed junction. (C) Drug can now enter, kill tumor cell.
Opus Effect
Friday, 05 June 2015
Samyang Biopharm, the Samyang Group's biopharmaceutical affiliate, announced on June 4 that it signed a contract with Seattle-based Compliment Corporation to introduce a technology for facilitating...
A schematic representation of in vivo spontaneous assembly of MSRs and the recruitment of host cells for maturation.
Enhancement of Treatment
Monday, 15 December 2014
A joint Korean and U.S. research team has successfully developed a material to deliver a 3D vaccine that can more effectively treat diseases like cancer or infections by activating immune cells...

Copyright 2013 BusinessKorea Co., Ltd.
301 Samdo Building, 12-1
Yeoido-dong, Yeongdeungpo-gu
Seoul, Korea 150-010
Tel: +82-2-578-3220
Fax: +82-2-578-3224
Email: contact@businesskorea.co.kr


This month Business Korea is sponsored by: